Don't get me wrong odie. I think the company is in great shape now with a great product that I always believed in. The first RS was done at the wrong time and they didn't have the financial numbers to make it work so the stock price tumbled. This time may be different and the leadership in place now has to show that they have the numbers to justify the stock price. It's just that two reverse splits put my cost basis way too high. Very few companies can make an RS work. They just use them to keep financing themselves on the backs of the shareholders, especially in the OTC stocks. CYRX has to get off the OTC and have the income to support the stock price. We shall see.
News 
Market Data 
Discover 
AI
